PLD plays an essential role in reducing ROS production and inhibiting the activation of NLRP3 inflammasome, thereby inhibiting pyroptosis and inflammatory damage in the HNEpCs of patients with CRS, as shown in Fig. 9. This evidence concerns the gene GPLD1 and congenital rubella syndrome.